Cryptogenic hemoptysis. Clinical features, bronchoscopic findings, and natural history in 67 patients

Ann Intern Med. 1985 Jun;102(6):829-34. doi: 10.7326/0003-4819-102-6-829.

Abstract

We reviewed the clinical outcome of 67 patients with hemoptysis and a normal or nonlocalizing chest roentgenogram and nondiagnostic fiberoptic bronchoscopic examination. During a 38 +/- 22 (SD) month period after bronchoscopy, 57 (85%) patients remained well without evidence of active tuberculosis or overlooked bronchogenic carcinoma, and 9 patients died of nonpulmonary conditions. One patient developed bronchogenic carcinoma 20 months after bronchoscopy and resolution of symptoms. Hemoptysis had resolved completely before hospital discharge in 38 (57%) patients, within 6 months in 60 (90%), and recurred in only 3. Five patients (7.5%) had intermittent episodes of bleeding for more than 1 year. Fiberoptic bronchoscopy effectively excludes specific underlying causes of hemoptysis in the setting of a normal chest roentgenogram. The prognosis for patients with cryptogenic hemoptysis is generally good, usually with resolution of bleeding within 6 months of evaluation.

MeSH terms

  • Adult
  • Aged
  • Anti-Bacterial Agents / therapeutic use
  • Bronchial Diseases / diagnosis
  • Bronchitis / diagnosis
  • Bronchoscopy*
  • Carcinoma, Bronchogenic / diagnosis
  • Evaluation Studies as Topic
  • Female
  • Fiber Optic Technology
  • Follow-Up Studies
  • Hemoptysis / drug therapy
  • Hemoptysis / etiology*
  • Hemoptysis / physiopathology
  • Humans
  • Lung Diseases / diagnosis
  • Lung Neoplasms / diagnosis
  • Male
  • Middle Aged
  • Prognosis
  • Recurrence
  • Tuberculosis, Pulmonary / diagnosis

Substances

  • Anti-Bacterial Agents